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We report on a 32-year-old male patient who presented to the emergency room for abdominal pain associated with nausea
and vomiting. The patient experienced these symptoms for the last 3 months and was taken in charge on an outpatient basis.
Assessment in the emergency room showed hemodynamic collapse, there were no signs of acute surgical abdomen. Emergent
cardiac echogram showed severely dilated hypokinetic cardiomyopathy. The diagnosis of acute heart failure associated with
nonocclusive mesenteric ischemia was retained. A review of the pertinent literature is presented.
1.Introduction
Heart failure (HF) patients commonly present with typical
signs like fatigue and dyspnea along with lower legs edema
when there is right ventricular involvement. Morbidity and
mortality from HF are signiﬁcantly higher when the diagno-
sis is delayed because of atypical presentation [1]. Nonocclu-
sive mesenteric ischemia (NOMI) is a rare condition com-
plicating the course of heart failure, and it is probably un-
derdiagnosed and is associated with a high mortality rate
[2]. Due to its dynamic and intermittent vasospastic phys-
iopathology, NOMI is still a challenging diagnostic concern,
and so far there is no standard diagnostic test of suﬃcient
sensitivity and speciﬁcity [3]. Early diagnosis of NOMI is
essential, also identiﬁcation of triggering factors is criti-
c a lt oi m p r o v eo u t c o m e[ 2, 3]. We present a case of severe
heart failure presenting with nonspeciﬁc gastrointestinal
(GI) symptoms compatible with NOMI.
2. Case Presentation
A 32-year-old male patient with no past medical history pre-
sented to the emergency room with abdominal pain, nausea,
and vomiting. The patient had “normal” bowel movements
and reported having these recurrent symptoms for the last 3
months. The patient was managed on an outpatient basis for
nonspeciﬁc functional GI disorders and was treated as such
with oral phloroglucinol and metoclopramide.
Initial assessment in the emergency room revealed a
blood pressure at 70/40mmHg, a heart rate at 120bpm, cold
extremities and general pallor, mild pulmonary rales, abdo-
minal bloating, and no lower leg edema. There was no signs
of acute surgical abdomen. Electrocardiogram showed sinus
tachycardia with narrow QRS and diﬀuse nonspeciﬁc ST/T
changes, chest X rays showed cardiomegaly, and emergent
cardiac echogram showed severe hypokinetic dilated cardi-
omyopathy (Figure 1) with ejection fraction at 25%, normal
pericardium, and no signiﬁcant intrinsic valvular disease.
The abdominal computed tomography (contrast-en-
hanced) scan showed nonspeciﬁc ﬁndings: no peritoneal ef-
fusion, no organic intraabdominal disease documented, and
slow progression of contrast material attributed to the poor
hemodynamic condition. Mesenteric angiography was not
performed due to the unstable hemodynamic condition and
the lack of consent.
Laboratory ﬁndings revealed negative troponin, mild
leucocytosis, serum sodium at 120mmol/L, creatinine at
1.7mg/dL, brain natriuretic peptide (BNP) at 3535pg/mL,2 Case Reports in Medicine
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Figure 1: Cardiac echogram (apical view) showing severe dilation
of 4 cavities.
glutamic oxaloacetic transaminase(GOT)at52U/L, glutam-
ic pyruvic transaminase (GPT) at 73U/L, lactate dehydro-
genase (LDH) at 271U/L, and serum lactate at 4.8mmol/L.
Amylase, lipase, cortisol level, and other routine laboratory
results were all within normal limits.
Intheevolution,abdominalpainwasresistanttoconven-
tionalanalgesicsandantispasmodics,anditwasonlyrelieved
when the hemodynamic condition improved. Also, during
theintensivecareunitstay,therewereparoxysmsofrecurrent
abdominal pain concomittant with episodic worsening of
the hemodynamic condition. Of note, the patient needed
intravenous positive inotropic agents for 14 days before the
hemodynamic condition stabilized.
3. Discussion
This case shows an atypical presentation of HF consisting
of abdominal syndrome compatible with NOMI. NOMI
is a functional mesenteric circulatory disorder caused by
a hypoperfusion state, it was ﬁrst described by Ende [4]
in patients with severe heart failure. Intestinal vasospasm
related to decreased cardiac output and persistent low
perfusion state is thought to be the underlying mechanism
of NOMI [5, 6]. Early symptoms are often vague and in
many cases, and the disease may progress to an advanced
stage before a deﬁnitive diagnosis is established. The con-
dition usually starts with nonspeciﬁc symptoms, consisting
generally of mild abdominal pain that gradually progresses
inseverity,alsobloatingsensation,nausea,andvomitingmay
develop and evoke a subocclusion or occlusion [5].
The ﬁrst issue to raise in this case report is that the
presenting GI syndrome is atypical as a presentation of
HF; this can be misleading and can explain the subsequent
delay in the diagnosis and management of both HF and
NOMI. Therefore, NOMI should be evoked every time that
unexplained persistent GI symptoms manifest in the setting
of a poor hemodynamic condition.
The second issue to raise is that deﬁnitive diagnosis of
NOMI is often diﬃcult, it is based essentially on clinical
settings, and abdominal computed tomography with helical
angiography is helpful when feasible but can be deceiving or
unreliable because of the dynamic, functional, and spastic
pattern of the disease [3, 5]; also angiography may not be
achievable due to its complexity and invasiveness in the
setting of unstable hemodynamic condition, and if per-
formed, the spasm may be relieved, thereby missing the
opportunity of accurate diagnosis [6, 7]. The activation
of the renin-angiotensin system and vasopressin secretion
are common in the setting of HF, and this phenomenon is
probably involved in the physiopathology of NOMI, mainly
the vasospasm of the splanchnic circulation; also the spasm
may be triggered with the vasoactive and cardiotonic drugs
given for HF [5]; among these, we list digitalis, furosemide,
and ergotamine [3].
Leucocytosis and elevated serum lactate are suggestive
of NOMI in this setting [3], corresponding to the degree
of intestinal ischemia and/or necrosis [8]; other laboratory
ﬁndings are often non speciﬁc.
The absence of congestive HF symptoms like dyspnea
and peripheral edema has been reported [9]i nas e r i e so f
patients despite severe depression of systolic function; the
asymptomatic status was associated with a preserved auto-
nomicfunctionthatwasconsideredhavingaprotectiveeﬀect
against the development of congestive HF symptoms despite
increasedlevelsofBNP.Giventhephysiopathologicalmecha-
nism of NOMI that is related to a severe functional intestinal
ischemia as a consequence of low perfusion state, NOMI is
more imputed to forward HF rather than backward HF.
In the presented case, we hypothesized that NOMI is
likely the cause of the abdominal syndrome according to
the following criteria: patient presenting with severe HF,
abdominal symptoms not relieved with classical analgesics
but only with hemodynamic improvement, the syndrome
relapsed when hemodynamic condition worsened, absence
of speciﬁc organic intraabdominal pathology, mild increase
in transaminases level. Other rare causes (i.e., porphyria,
addison) of this abdominal presentation are to be evoked,
but given the association between the relief of symptoms
and improvement of the hemodynamic status, we refrained
from performing extensive paraclinical tests in this setting.
Mesenteric angiography is the standard test for the diagnosis
of NOMI [3]; it shows in up to 90% of cases mesenteric
vasoconstriction, impaired ﬁlling of intramural vessels, and
regional vasospasm.
4. Conclusion
NOMI is a critical condition that worsen the prognosis of
patients with poor and unstable hemodynamic condition.
Although it is a rare condition, it should be evoked in this
clinicalsetting;alsoamultidisciplinaryapproachisofutmost
importance in order to improve outcome.
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